Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing

PUBT · 1d ago
Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing
  • Aspen Neuroscience’s amended and restated bylaws became effective Nov. 2, 2026, in connection with its IPO closing.
  • The IPO comprised 9,375,000 common shares priced at $15 per share.
  • Gross proceeds totaled approximately $140.6 million before underwriting discounts, commissions and offering expenses.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-443805), on November 02, 2026, and is solely responsible for the information contained therein.